-
Featured
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
Researchers in the OB/GYN Department are working to combat the opioid epidemic and mitigate its effects. Recent efforts have focused on preventing opioid use and misuse through a variety of methods including optimized prescribing practices.
-
Featured
Fighting Zika Virus on Multiple Fronts: Identifying Risk, Improving Screening and Investigating Pregnant Women's Vaccination Attitudes
Obstetricians at Mass General are working to fight the Zika epidemic on multiple fronts by guiding decision-making about testing for Zika infection, filling knowledge gaps about Zika risks and develop testing protocols and understanding pregnant women’s attitudes about Zika vaccines to help guide vaccine development.
-
Featured
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
A multidisciplinary, 1000-day clinical model offers a new approach to prenatal and postnatal care for mothers with opioid use disorder and their children.
-
YAP1 Oncogene Synergizes with HPV to Promote Cervical Cancer
Researchers have provided in vitro and in vivo evidence that the YAP1 oncogene can induce cervical cancer regardless of HPV infection. Further, the synergism between HPV and YAP1 significantly accelerates the development of cervical cancer and HPV vaccination remains vitally important.
-
Medicaid Expansions Improved Preconception Coverage for Low-income Women
Following the passage of the Affordable Care Act, the Medicaid expansions supported by the federal government were associated with significant increases in preconception insurance coverage for low-income women, according to a study by obstetrician–gynecologists and health policy analysts at Mass General.
-
Exploring the Relationship Between Maternal Obesity and Adverse Fetal Neurodevelopment
Evidence from a pilot study suggests that maternal obesity primes macrophages in the fetal brain and placenta to overrespond to immune challenge. Male fetuses may be more vulnerable to this proinflammatory priming.
Obstetrics contributors
-
Davida M. Schiff, MD
Medical Director, HOPE Clinic, Instructor, Pediatrics, Harvard Medical School
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Fighting Zika Virus on Multiple Fronts: Identifying Risk, Improving Screening and Investigating Pregnant Women's Vaccination Attitudes
-
Jeffrey L. Ecker, MD
Chief, Department of Obstetrics & Gynecology
Recent Article
Confronting the Opioid Epidemic in the OB/GYN Practice: Optimizing Prescribing Habits and Reducing Opioid Misuse
-
Jessica R. Gray, MD
Clinical director, HOPE Clinic, Family medicine addiction specialist
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
Sarah N. Bernstein, MD
Maternal Fetal Medicine Specialist, Medical director, Outpatient Obstetrics Program
Recent Article
Perinatal Substance Use Clinic: Multidisciplinary Care from Pregnancy to Early Childhood
-
William H. Barth, MD
Vice Chair, Obstetrics
Recent Article
Liposomal Bupivacaine Block Similar to Placebo for Pain Reduction After Cesarean
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.
